Safety and pharmacokinetics of subcutaneous administration of broadly neutralizing anti-HIV-1 monoclonal antibodies (bNAbs), given to HIV-1 exposed, uninfected neonates and infants: study protocol for a phase I trial
对暴露于 HIV-1 但未感染的新生儿和婴儿皮下注射广谱中和抗 HIV-1 单克隆抗体 (bNAbs) 的安全性和药代动力学：一项 I 期试验的研究方案
期刊:BMC Infectious Diseases
影响因子:3
doi:10.1186/s12879-024-09588-3
Goga, Ameena; Ramraj, Trisha; Naidoo, Logashvari; Daniels, Brodie; Matlou, Masefetsane; Chetty, Terusha; Dassaye, Reshmi; Ngandu, Nobubelo K; Galli, Laura; Reddy, Tarylee; Seocharan, Ishen; Ndlangamandla, Qondeni; September, Qholokazi; Ngcobo, Nokwanda; Reddy, Mayuri; Cafun-Naidoo, Tamon; Woeber, Kubashni; Jeenarain, Nitesha; Imamdin, Rabia; Maharajh, Keshnee; Ramjeth, Ashmintha; Bhengu, Thobile; Clarence, Emma; Van de Perre, Philippe; Tylleskär, Thorkild; Nagot, Nicolas; Moles, Jean-Pierre; Moore, Penny L; Mkhize, Nonhlanhla N; Gama, Lucio; Dispinseri, Stefania; Biswas, Priscilla; Scarlatti, Gabriella
